Archive for the ‘Lyme’ Category

Lyme Advocacy Webinar Oct. 28, 2021

https://www.lymedisease.org/advocacy-webinar-oct28/

Dorothy Kupcha Leland

Oct. 4, 2021

Many people who have Lyme disease themselves—or have a loved one with Lyme—want to do something to change the status quo.

You know what I’m talking about—the current situation that leaves so many Lyme patients in the lurch. Few doctors willing to treat them, little to no Lyme insurance coverage, ineffective tests, denial by public health officials—the list goes on and on.

Can one person make a difference? And if so, where does that one person begin? Well, I have a suggestion.

I recommend you start by registering for the free webinar called Advocacy Q & A, sponsored by Project Lyme. Its goal is to help you learn how to get involved with Lyme advocacy at the federal, state and individual levels. It will be held via Zoom on October 28, at 5:30 p.m. Eastern Time (2:30 p.m. Pacific Time).

I’m honored they asked me to participate. I’ll share insights from my 15 years of advocacy with LymeDisease.org, and discuss how the MyLymeData project helps drive patient engagement for healthcare reform.

I’ll be joined by Bonnie Crater, co-founder of the Center for Lyme Action, a group that lobbies in Washington to increase federal funding for Lyme disease. CLA is best known in the Lyme community for its annual Lyme Fly-in. She’ll tell us all how to get involved with 2022’s event.

Also on the panel will be Holiday Goodreau, Executive Director of the LivLyme Foundation and co-creator of the free global app Tick Tracker. She was recently named as co-chair of the federal Tick-Borne Disease Working Group. Like me, she’s the mother of a daughter with Lyme.

Click here to register.

TOUCHED BY LYME is written by Dorothy Kupcha Leland, LymeDisease.org’s Director of Communications. She is co-author of When Your Child Has Lyme Disease: A Parent’s Survival Guide. Contact her at dleland@lymedisease.org.

Drug Treatment for Lyme Disease Could Lead to its Eradication

https://www.newscientist.com/article/2292543-drug-treatment-for-lyme-disease-could-lead-to-its-eradication

Drug treatment for Lyme disease could lead to its eradication

6 October 2021
Borrelia burgdorferi bacteria

Microscopic image of Borrelia burgdorferi bacteria

Cultura Creative RF/Alamy

The discovery that a chemical is deadly to the bacterium that causes Lyme disease but harmless to animals might allow the disease to be eradicated in the wild.

“Lyme disease is well-positioned to be eradicated,” says Kim Lewis at Northeastern University in Boston. “We are gearing up, the first field trial will be next summer.”  (See link for article)

___________________

Important points:

  • Lewis’s team is looking at hygromycin
  • The team didn’t notice any harmful effects in animals no matter now high the dose
  • FlightPath is now filing in the US for the initial go-ahead required before the chemical can be tested in people
  • A Field trial a decade ago using doxycycline baits for mice was successful, but widespread use could lead to antibiotic resistance
  • Lewis’s studies suggest resistance to hygomycin would be difficult due to the way it resembles essential nutrients spirochetes need for survival

Journal reference: Cell, DOI: 10.1016/j.cell.2021.09.011

_________________

https://news.northeastern.edu/2021/10/06/preventing-chronic-lyme-disease/

Could this treatment prevent chronic Lyme disease?

Chronic Lyme disease has frustrated doctors and patients alike for years. The severe, lingering symptoms, such as chronic fatigue, muscle and joint pain, arthritis, or cognitive difficulties, have disrupted patients’ lives and treatments have been elusive.

But what if there was a way to prevent acute Lyme disease from progressing to the longer-term version?

That’s the premise that has driven Kim Lewis’ research. And now, the university distinguished professor of biology and director of the Antimicrobial Discovery Center at Northeastern says he has found a targeted treatment for acute Lyme disease that could do just that. (See link for article)

_______________

Important points:

  • Doxycycline, the antibiotic commonly used to treat Lyme disease is a broad spectrum antibiotic that kills indiscriminately, wiping out ones beneficial to health
  • Lewis found in previous research that chronic Lyme patients have a gut microbiome distinct from healthy individuals
  • Hygromycin A, found in soil, was discovered in 1953 but was dismissed as ineffective
  • It appears to be potent against spirochetes
  • Lewis’s team is also studying whether Hygromycin A can treat other spirochetal diseases like syphilis

COVID Impacts on Lyme Disease Reporting

https://wwwnc.cdc.gov/eid/article/27/10/21-0903_article

Research Letter

Effects of COVID-19 Pandemic on Reported Lyme Disease, United States, 2020

David W. McCormickComments to Author , Kiersten J. Kugeler, Grace E. Marx, Praveena Jayanthi, Stephanie Dietz, Paul Mead, and Alison F. Hinckley
Author affiliations: Centers for Disease Control and Prevention, Fort Collins, Colorado, USA. (D.W. McCormick, K.J. Kugeler, G.E. Marx, P. Mead, A.F. Hinckley); ICF International Inc., Atlanta, Georgia, USA (P. Jayanthi); Centers for Disease Control and Prevention, Atlanta (P. Jayanthi, S. Dietz)

Cite This Article

Abstract

Surveys indicate US residents spent more time outdoors in 2020 than in 2019, but fewer tick bite–related emergency department visits and Lyme disease laboratory tests were reported. Despite ongoing exposure, Lyme disease case reporting for 2020 might be artificially reduced due to coronavirus disease–associated changes in healthcare-seeking behavior.

The coronavirus disease (COVID-19) pandemic has altered how humans interact with their environment and the healthcare system (1,2), and strained resources have limited the ability of state and local health departments to respond to reports of notifiable diseases (3). The Centers for Disease Control and Prevention (CDC) typically is notified of 30,000–40,000 Lyme disease cases annually (4), but the COVID-19 pandemic likely will affect the case counts. Most Lyme disease cases are acquired in spring and early summer (5); in 2020, these seasons coincided with the initial spread of COVID-19 and widespread stay-at-home orders. We explored 4 data sources to assess how the COVID-19 pandemic might have influenced tick bite risk and associated healthcare-seeking practices and affected reported Lyme disease cases for 2020.

The pathway for Lyme disease case reporting begins with environmental risk and culminates with case notification to CDC (Appendix Figure). Environmental risk is relatively stable in high-incidence areas and driven by ecologic factors unaffected by COVID-19 (6). The pandemic might have altered the frequency of outdoor activities and probability of encountering ticks, healthcare-seeking and provider services patterns, and case investigation and reporting. The data sources we used measure changes in time spent outdoors, information-seeking patterns for tick removal, emergency department (ED) visits for tick bites, and laboratory testing for Lyme disease. This analysis was considered nonhuman subjects research by CDC.

To assess potential behavior shifts that might have increased risk for tick encounters, we analyzed data from Porter Novelli’s PN View 360+ consumer survey (7). Among 4,013 participants who responded to the survey distributed during July 31–August 9, 2020, approximately half (49.9%) reported that they had spent a lot more time or slightly more time outdoors by that point in 2020 compared with prior years. Only 20.9% of respondents reported spending less time outdoors in 2020.

Comparison of visits to the Centers for Disease Control and Prevention (CDC) website on tick removal, 2018–2020, and to the ED for tick-bite related chief complaints, 2017–2020, United States. A) Website visits per month for https://www.cdc.gov/ticks/removing_a_tick.html. B) ED visits by month in which the chief health complaint was tick bite. Comparison of 2020 to the average of the previous 4 years is shown. ED, emergency department.Figure. Comparison of visits to the Centers for Disease Control and Prevention (CDC) website on tick removal, 2018–2020, and to the ED for tick-bite related chief complaints, 2017–2020, United States. A)…

To indirectly assess frequency of tick encounters in 2020 compared with prior years, we evaluated total monthly visits during 2018–2020 to a CDC website describing tick removal (8). Visits to this website typically increase during late spring and summer and again in October, when most bites from blacklegged ticks (Ixodes scapularis and Ixodes pacificus) occur (5). We observed 818,167 website visits during 2020, ≈25% more than in 2019 (681,021) and 2018 (630,839) (Figure).

To assess patterns related to healthcare-seeking for tick encounters, we identified ED visits for tick bites by using the National Syndromic Surveillance Program (NSSP) BioSense platform (9). ED visits for tick bites decreased in 2020 from 2019 in both total number and rate per 100,000 ED visits (Figure). The largest relative decreases were observed in May. During 2017–2019, the average number of ED visits for tick bites during the month of May was 12,693, an average rate of 145/100,000 ED visits. During May 2020, only 5,845 ED visits for tick bites occurred, a rate of 89/100,000 ED visits.

We quantified cumulative counts and percent positivity of serologic tests for Lyme disease performed by an independent clinical laboratory. Lyme disease testing volume decreased from 2019 to 2020; 25.0% fewer tests were performed, and test positivity decreased slightly to <1% (Table).

During the first wave of the COVID-19 pandemic in 2020, the US population spent more time outdoors and visited a CDC website describing safe tick removal more frequently than during prior years. However, fewer persons sought care for tick bites, and substantially fewer laboratory tests for Lyme disease were ordered. These findings suggest that the risk of acquiring Lyme disease was similar or potentially higher in 2020 compared with risk during prior years, but fewer persons sought care, and fewer positive laboratory reports were referred for case investigation. Consequently, we anticipate that, once ultimately finalized, the official number of confirmed and probable Lyme disease cases in 2020 will be substantially lower than that for prior years.

One limitation of our study is that data sources we examined represent national trends and are indirect surrogates for Lyme disease risk and reporting, which vary geographically. Visits to a website describing tick removal might not correspond with finding an attached tick. Available data on laboratory testing represents 1 independent clinical laboratory; other commercial or academic laboratories might not have experienced a similar decrease in testing. Data sources associated with telehealth utilization and prescription claims could provide additional insights into the diagnosis and treatment for Lyme disease in 2020.

Already an issue in high-incidence states, the pandemic has highlighted the need for alternative Lyme disease surveillance strategies that rely less on human resources. An anticipated and potentially substantial decrease in reported Lyme disease in 2020 likely reflects the effects of the COVID-19 pandemic rather than a true change in Lyme disease incidence. Decreased reporting also could render 2020 inconsistent with long-term trends and changes in the epidemiology of the disease. Although nonpharmaceutical interventions for COVID-19 have mitigated the transmission of respiratory pathogens (10), these results suggest the behavioral and reporting changes seen for Lyme disease might extend to other nonrespiratory diseases.

Dr. McCormick is an Epidemic Intelligence Service Officer in the Bacterial Diseases Branch, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado. His primary research interests are the epidemiology and prevention of bacterial vectorborne diseases.

Acknowledgment

We thank Melanie Spillane for her assistance with collating data from National Syndromic Surveillance Program and Anna Perea for assistance with Porter Novelli’s PN View 360+ consumer survey data.

References

  1. Hartnett  KP, Kite-Powell  A, DeVies  J, Coletta  MA, Boehmer  TK, Adjemian  J, et al.; National Syndromic Surveillance Program Community of Practice. Impact of the COVID-19 pandemic on emergency department visits—United States, January 1, 2019–May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:699704. DOIExternal LinkPubMedExternal LinkGoogle ScholarExternal Link
  2. Czeisler  , Marynak  K, Clarke  KEN, Salah  Z, Shakya  I, Thierry  JM, et al. Delay or avoidance of medical care because of COVID-19–related concerns—United States, June 2020. MMWR Morb Mortal Wkly Rep. 2020;69:12507. DOIExternal LinkPubMedExternal LinkGoogle ScholarExternal Link
  3. Weber  L, Ungar  L, Smith  MR, Recht  H, Barry-Jester  AM. Hollowed out public health system faces more cuts amid virus. Associated Press. 2020 Jul 1 [cited 2021 Apr 20]. https://apnews.com/article/b4c4bb2731da9611e6da5b6f9a52717aExternal Link
  4. Schwartz  AM, Hinckley  AF, Mead  PS, Hook  SA, Kugeler  KJ. Surveillance for Lyme disease—United States, 2008–2015. MMWR Surveill Summ. 2017;66:112. DOIExternal LinkPubMedExternal LinkGoogle ScholarExternal Link
  5. Mead  PS. Epidemiology of Lyme disease. Infect Dis Clin North Am. 2015;29:187210. DOIExternal LinkPubMedExternal LinkGoogle ScholarExternal Link
  6. Burtis  JC, Sullivan  P, Levi  T, Oggenfuss  K, Fahey  TJ, Ostfeld  RS. The impact of temperature and precipitation on blacklegged tick activity and Lyme disease incidence in endemic and emerging regions. Parasit Vectors. 2016;9:606. DOIExternal LinkPubMedExternal LinkGoogle ScholarExternal Link
  7. Porter Novelli. ConsumerStyles & YouthStyles 2021 [cited 2021 Apr 20]. http://styles.porternovelli.com/consumer-youthstylesExternal Link
  8. Centers for Disease Control and Prevention. Tick removal [cited 2021 Apr 20]. https://www.cdc.gov/ticks/removing_a_tick.html
  9. Marx  GE, Spillane  M, Beck  A, Stein  Z, Powell  AK, Hinckley  AF. Emergency department visits for tick bites—United States, January 2017–December 2019. MMWR Morb Mortal Wkly Rep. 2021;70:6126. DOIExternal LinkPubMedExternal LinkGoogle ScholarExternal Link
  10. Olsen  SJ, Azziz-Baumgartner  E, Budd  AP, Brammer  L, Sullivan  S, Pineda  RF, et al. Decreased influenza activity during the COVID-19 pandemic-United States, Australia, Chile, and South Africa, 2020. Am J Transplant. 2020;20:36815. DOIExternal LinkPubMedExternal LinkGoogle ScholarExternal Link

[#MeAgain] From Crippling Pain to Living Life: Trish Laube’s Battle With Lyme

https://rawlsmd.com/health-articles/meagain-from-crippling-pain-to-living-life-trish-laubes-battle-with-lyme?

[#MeAgain] From Crippling Pain to Living Life: Trish Laube’s Battle With Lyme

By Lindsey Shaffer
Posted 9/29/21

“At the beginning, I had crippling pain. My joints were so bad that I couldn’t get up and walk to the bathroom.”

In the summer of 2016, after spending much of the spring and summer months in her garden, Trish Laube began experiencing strange and painful symptoms. “I kept pointing to my feet, asking people, ‘Can you see anything crawling there?’” she explains.

Trish was no stranger to challenging health circumstances. In 2004, she was diagnosed with retinitis pigmentosa, a rare, progressive eye disease, which left her legally blind. But these new symptoms were unlike anything she’d experienced before. After doing some research, Trish began to suspect she was dealing with either some type of cancer or Lyme disease. “I felt like I was going to die,” she remembers.

“I told him I wanted to be tested for Lyme, and he fought me on it”Trish visited her doctor and told him about the symptoms she was experiencing. “I told him about the neurological problems and about my extreme fatigue,” she says. “I would wake up and race to get something done before my eyes shut again, but I couldn’t. I was forced to take a nap and then get back up and try it again.”

Trish’s doctor wanted to send her for a three-month-long sleep study, but Trish knew her symptoms would only continue to worsen during that time. “I told him I wanted to be tested for Lyme, and he fought me on it,” Trish says.

He sent her for an ultrasound, which came back negative. Next, she underwent an X-ray and was diagnosed with spinal stenosis. “The neurologist diagnosed me with some type of migraines, and the doctor said I had chronic fatigue syndrome, but I wanted a test for Lyme,” Trish explains.

Trish holding a child while sitting on a benchFinally, Trish’s doctor agreed to the test. While she waited for the results, Trish began researching Lyme disease and possible treatment paths. “I started looking up natural remedies, natural holistic care, and Dr. Rawls’ website came up,” Trish explains. “I read everything on there, I watched every video, and I learned more than I would’ve ever known I could learn in three weeks.”

Sure enough, Trish’s Lyme test came back positive. And her doctor said she was his first patient with Lyme disease. “The doctor said, ‘you were right; you are positive for Lyme, and I called in a prescription for you,’” says Trish. “But I told him I wasn’t going to take it.”

Instead, Trish told her doctor she would try Dr. Rawls’ herbal protocol. “Within six months, the only things I had left were pressure in my head, which caused balance issues, and a lingering salty taste in my mouth,” she says.

“I think the only prevention is keeping our immune system as strong as possible”Trisha began adding other therapies into her treatment protocol as well, and following a professional lymphatic drainage massage, the constant salty taste resolved permanently. She also incorporated Epsom salts baths, jumping on a mini trampoline, portable infrared sauna sessions, and toxin binders like bentonite clay and chlorella. A few months later, the head pressure was gone, too.

Trish has been symptom-free as of August 2018, and she got there by taking full doses of the herbal protocol. She also uses Dr. Rawls’ recommended herbs for gut health every three months to keep her digestive tract working as efficiently as possible.

Trish at taekwondo, dressed in uniformTrish has no intentions of slowing down. “I think the only prevention is keeping our immune system as strong as possible, and Dr. Rawls’ herbal protocol does that for me,” she says. “I don’t plan on ever coming off of it. Keeping my immune system strong is my best form of defense.”

Trish’s diagnosis hasn’t kept her indoors or held her back from living her life. “I’m back in my garden. I’m finally able to ride on the back of my husband’s motorcycle with him. I’m out walking again every day. I lost 120 pounds in 14 months,” she says. “I don’t let fear run my life. I’m back out doing everything I’ve ever done.”

Additionally, Trish is hugely passionate about helping the chronic illness and disability communities live life to the fullest. Most days, you can find her actively answering other patients’ questions on online Lyme forums. She also started her own group, VP Members Rise above Challenges, to connect with others and help people turn their hobbies into an income from the comforts of their own homes.

“Being disabled since 2004 helped me a lot because I had already lived through many of the experiences that Lyme would bring about,” she says. “The main message I want people to understand is not to give up. Know that you can come out on the other side of all of this.”

___________________

**Comment**

Warning: people respond quite differently to treatment protocols and while I’m ecstatic when I hear success stories, please know every case is different.

Further, one of the most experienced doctors told me that cases in the 70’s could be resolved within a couple of months to a year but that cases now are taking over 3 years to resolve.  It appears coinfections are playing a larger role and patients often struggle with numerous pathogens as well as things like mold, MCAS, and other issues that cause more severe cases.

Please don’t let this story dishearten you if you have to continue to fight a hard battle.  Chin up and keep going.  Don’t quit.

For a comparison, it took my husband and I 5 years of treatment using every thing under the sun before we stopped treatment.  We’ve relapsed 3 times since then, requiring treatment for 2-3 months to get us back.  For us, we seem to relapse with Bartonella – so sometimes it isn’t even Lyme that keeps you down.  Keep an open mind, keep learning, and again – never, ever quit.

For more:

Lyme Disease Triggers Vertigo & Hearing Loss

https://danielcameronmd.com/lyme-disease-vertigo-hearing-loss/

Lyme disease triggers vertigo and hearing loss

woman with lyme disease and vertigo sitting and holding head

Vertigo (spinning sensation or feeling off balance) and hearing loss have been reported in several studies as symptoms of Lyme disease. One study found 4 out of 27 patients with neurologic Lyme disease experienced hearing loss.¹ Vertigo was reported in 5 out of 8 Lyme disease patients (62.5%) by Selmani et al.² Additionally, investigators suggest that vertigo can be the predominant symptom in patients with confirmed Lyme disease — its symptoms resembling neuronitis vestibularis in the acute stage.³

A recently published study by Sowula and colleagues provides further evidence that Lyme disease can trigger vertigo and hearing loss. In their article “Vertigo as one of the symptoms of Lyme disease,” the authors examine the frequency of vertigo symptoms and potential labyrinth damage in patients with diagnosed Lyme disease.4

The study included 38 patients (ages 20 to 77) with Lyme disease, who were hospitalized at University Hospital in Krakow, Poland, between 2018 and 2019, due to vertigo or dizziness.

“One alleged group of diseases which can trigger vertigo involves infectious diseases of the nervous system,” the authors explain.

“Many pathogens are said to be in part responsible for inflammation; among them are spirochetes of Borrelia [the causative agent of Lyme disease] as well as other pathogens transmitted by ticks.”

The study found:

  • 76% of the Lyme disease patients reported vertigo (54% of them were woman compared to 22% of men);
  • Hearing loss and tinnitus were symptoms which frequently accompanied vertigo;
  • 1 in 3 patients experienced sensorineural hearing loss (SNHL), which was bilateral in 2 individuals and presented as sudden deafness in 2 other individuals. The hearing loss was significant for high frequency hearing loss but not low frequency hearing loss;
  • Tinnitus was reported in 3 out of 5 of the Lyme disease patients, the majority of whom experienced high frequency tinnitus.

“Increasingly, tick-borne illnesses [such as Lyme disease] are a potential cause of neurological symptoms reported by patients, including hearing loss, tinnitus, ataxia and vertigo.”

The authors conclude:

“It [vertigo] is frequently connected with labyrinth damage and hearing-organ impairment, which suggests that in the course of this disease the inner ear or nerve VIII is dysfunctional … Antibiotic therapy is effective in reducing otoneurological symptoms.”4

References:
  1. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med. Nov 22 1990;323(21):1438-44. doi:10.1056/NEJM199011223232102
  2. Selmani, Z.; Pyykkö, I. Cochlear and vestibular functional study in patients with sudden deafness an Lyme disease. IJOHNS 2014,3, 46–50.
  3. Ishizaki, H.; Pyykkö, I.; Nozue, M. Neuroborreliosis in the etiology of vestibular neuronitis. Acta Otolaryngol Suppl. 1993, 503,
    67–69.
  4. Sowula K, Szaleniec J, Dworak M, et al. Vertigo as One of the Symptoms of Lyme Disease. J Clin Med. Jun 25 2021;10(13)doi:10.3390/jcm10132814

_________________

For more: